Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs UFT in Resected NSCLC
NCT00139971Phase 3Unknown
- Sponsor
- West Japan Oncology Group
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by West Japan Oncology Group. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00139971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139971.